Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
45.39 USD | +2.39% | +5.68% | +1.38% |
07:48am | Qiagen's Updated Clinical Decision Support Platform Secures EU Certification | MT |
May. 13 | Qiagen Receives FDA Clearance for Clinical Use of Respiratory Infection Test | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.38% | 10.07B | |
+29.03% | 49.18B | |
-0.10% | 42.11B | |
+46.68% | 40.37B | |
-5.26% | 28.85B | |
+11.48% | 26.09B | |
-22.74% | 18.71B | |
+9.06% | 13.26B | |
+30.01% | 12.32B | |
-1.51% | 11.99B |
- Stock Market
- Equities
- QGEN Stock
- News Qiagen N.V.
- BofA Securities Raises Price Target on Qiagen to $55 From $52, Maintains Buy Rating